dietary isoflavinoids may disrupt the entire body hormonal balance

[Lani]

EVEN without changing the circulating levels of TSH and thyroid hormone they may alter how the cells can use thyroid hormone and all the other hormones which communicate and feedback via the hypothalamus-pituitary-thyroid hormone axis and they cross the placenta !!!!!


Effects of isoflavonoids and other plant-derived compounds on the hypothalamus–pituitary–thyroid hormone axis


Inka Hamanna, , , D. Seidlova-Wuttkeb, W. Wuttkeb and J. Köhrlea

aInstitut für Experimentelle Endokrinologie und Endokrinologisches Forschungszentrum, Charité, Universitätsmedizin Berlin, Charitéplatz 1, D-10117 Berlin, Germany
bDepartment of Clinical and Experimental Endocrinology, University of Goettingen, Robert-Koch-Str. 40, D-37075 Goettingen, Germany


Available online 9 August 2006.



Abstract

Objectives

There is increasing concern that exposure to flavonoids may lead to endocrine disruption of the hypothalamus–pituitary–thyroid hormone axis, and, additionally, there is evidence that secondary plant metabolites contained in our daily diet or used for hormone-replacement therapy act as hormones themselves, similar to known isoflavonoid effects in the steroid hormone network. These compounds of natural origin affect the thyroid hormone feedback system by interference with different components of this homeostatically regulated system: biosynthesis, secretion and metabolism, transport, distribution, and action of thyroid hormones including the feedback mechanism. Genistein and daidzein, the major components of soy, influence thyroid hormone synthesis by inhibition of the iodide oxidizing enzyme thyroperoxidase, interfere with thyroid hormone transport proteins and 5?-deiodinase type I activities in peripheral tissues, which leads to altered thyroid hormone action at the cellular level. Synthetic flavonoids, such as F21388, structurally similar to thyroxine, cross the placenta and reach the fetal brain of animal models also.

Methods

A review of effects of various isoflavonoids and plant-derived extracts on the hypothalamus–pituitary–thyroid axis is the major objective of this contribution. In addition, new experimental data obtained in ovariectomized (ovx) rats will be presented. The substances tested here were plant extracts of Agnus castus, Belamcanda chinensis, Silybum marianum, Cimicifuga racemosa, and a commercially available soy product.

Results

In ovx rats the extract at two doses showed no effects on circulating TSH and thyroid hormone serum levels after 3 months of treatment.

Conclusion

The thyroid hormone network has a considerable capacity to compensate for disturbances of this feedback system as it is necessary for various metabolic and catabolic reactions and development. With respect to still insufficient nutritive iodine-supply of almost one third of the world population, possible adverse flavonoid actions on the thyroid hormone axis have to be examined more closely.

Keywords: Isoflavonoid; Secondary plant metabolites; Soy; Genistein; Cimicifuga racemosa; Thyroid hormone; Thyroperoxidase; Transthyretin; 5?-Deiodinase

[Lani]

doi:10.1016/j.maturitas.2006.06.021
Copyright © 2006 Elsevier Ireland Ltd All rights reserved.
Plant extracts for the treatment of menopausal women: Safe?


Wolfgang Wuttke, a, , Guillermo Rimoldia, Julie Christoffela and Dana Seidlova-Wuttkea

aDepartment of Clinical and Experimental Endocrinology, University of Goettingen, Robert-Koch-Strasse 40, D-37075 Göttingen, Germany


Available online 8 August 2006.



Abstract

Objectives

The recently published data concerning putatively dangerous effects of classical hormone therapy resulted in increased sales of plant derived substances, which claim beneficial effects on climacteric and postmenopausal complaints and diseases. Soy and red clover extracts containing isoflavones have estrogenic effects in cell biological and animal experimental models but commercial advertisements often claim beneficial effects in mammary glands by preventing occurrence of malignancies. Black cohosh preparations are also increasingly used, and they appear to be devoid of estrogenic effects in the uterus. Their effects in the mammary gland have not yet been thoroughly studied.

Methods

Therefore, we studied the effects of genistein, the main isoflavone in soy or red clover preparations and of the black cohosh extract Cimicifuga racemosa (CR) or Actea racemosa BNO 1055 in the uterus and mammary gland of ovariectomized (ovx) rats and compared them with the effects of estradiol. Serum LH levels were also measured as an indicator of a hypothalamic/pituitary effects of the test substances.

Results

Genistein and E2, both stimulated uterine weight and several estrogen regulated genes. Lobulo-alveolar growth of 20 mammary glands as well as the expression of the nuclear protein proliferating cell nuclear antigen (PCNA, a proliferation marker) was also stimulated by E2 and genistein. The CR extract BNO 1055 was devoid of such estrogenic effects in the uterus and mammary gland. E2 and to lesser degree CR inhibited serum LH levels whereas genistein had no effects on this hormone.

Conclusions

E2 and genistein share uterotropic and mammatropic effects in ovx rats. If occurring in postmenopausal women this may endanger these organs to develop malignancies. Serum LH levels were inhibited by E2 and the CR BNO 1055 extract whereas genistein had no estrogenic effect in the hypothalamus and it is therefore unlikely that genistein inhibits climacteric complaints.

Keywords: Soy; Isoflavones; Estradiol; Black cohosh; Uterus; Mammary gland

[R.B.]

This is a good article on foods and hormone levels.

http://cebp.aacrjournals.org/cgi/content/full/10/1/25